Wetzel Investment Advisors, Inc. Viking Therapeutics, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 3,600 shares of VKTX stock, worth $237,528. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,600
Previous 2,000
80.0%
Holding current value
$237,528
Previous $37,000
697.3%
% of portfolio
0.17%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
430Shares Held
63.3MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$546 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$514 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$237 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$219 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$154 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...